Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Relapses in PR3-ANCA-associated Vasculitis
NCT00128895Phase 4Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2003
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of azathioprine in Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Disease Free Survival at 4 years. Started Jun 2003; status: terminated.
02
Drugs
azathioprine
03
Conditions
Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)
Beyond the preview
Go deeper on NCT00128895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128895.